Disparities in the speed at which patients in different European countries get access to the latest cancer drugs were highlighted last month in a report published by Stockholm’s Karolinska Institute. The Roche-sponsored study, launched at a press conference at the European Parliament, shows that patients in Austria, Spain and Switzerland tend to get quickest access, with patients in the UK, Czech Republic, Hungary, Norway and Poland lagging behind.
Leave a Reply